These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9627130)

  • 1. Vaccine-induced Th1-type responses are dominant over Th2-type responses in the short term whereas pre-existing Th2 responses are dominant in the longer term.
    Fernando GJ; Stewart TJ; Tindle RW; Frazer IH
    Scand J Immunol; 1998 May; 47(5):459-65. PubMed ID: 9627130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A vaccine conjugate of 'ISCAR' immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1- and Th2-type responses in immunized mice in the absence of oil-based adjuvants.
    Tindle RW; Croft S; Herd K; Malcolm K; Geczy AF; Stewart T; Fernando GJ
    Clin Exp Immunol; 1995 Aug; 101(2):265-71. PubMed ID: 7544248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th2-type CD4+ cells neither enhance nor suppress antitumor CTL activity in a mouse tumor model.
    Fernando GJ; Stewart TJ; Tindle RW; Frazer IH
    J Immunol; 1998 Sep; 161(5):2421-7. PubMed ID: 9725239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prototype Alzheimer's disease epitope vaccine induced strong Th2-type anti-Abeta antibody response with Alum to Quil A adjuvant switch.
    Ghochikyan A; Mkrtichyan M; Petrushina I; Movsesyan N; Karapetyan A; Cribbs DH; Agadjanyan MG
    Vaccine; 2006 Mar; 24(13):2275-82. PubMed ID: 16368167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epicutaneous immunization converts subsequent and established antigen-specific T helper type 1 (Th1) to Th2-type responses.
    Strid J; Callard R; Strobel S
    Immunology; 2006 Sep; 119(1):27-35. PubMed ID: 16764688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both E7 and CpG-oligodeoxynucleotide are required for protective immunity against challenge with human papillomavirus 16 (E6/E7) immortalized tumor cells: involvement of CD4+ and CD8+ T cells in protection.
    Kim TY; Myoung HJ; Kim JH; Moon IS; Kim TG; Ahn WS; Sin JI
    Cancer Res; 2002 Dec; 62(24):7234-40. PubMed ID: 12499264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB.
    Verma V; Tan W; Puth S; Cho KO; Lee SE; Rhee JH
    J Transl Med; 2016 May; 14(1):135. PubMed ID: 27184355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ISCOMATRIX adjuvant: an adjuvant suitable for use in anticancer vaccines.
    Stewart TJ; Drane D; Malliaros J; Elmer H; Malcolm KM; Cox JC; Edwards SJ; Frazer IH; Fernando GJ
    Vaccine; 2004 Sep; 22(27-28):3738-43. PubMed ID: 15315854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides.
    Zwaveling S; Ferreira Mota SC; Nouta J; Johnson M; Lipford GB; Offringa R; van der Burg SH; Melief CJ
    J Immunol; 2002 Jul; 169(1):350-8. PubMed ID: 12077264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streptococcus pneumoniae fructose-1,6-bisphosphate aldolase, a protein vaccine candidate, elicits Th1/Th2/Th17-type cytokine responses in mice.
    Elhaik Goldman S; Dotan S; Talias A; Lilo A; Azriel S; Malka I; Portnoi M; Ohayon A; Kafka D; Ellis R; Elkabets M; Porgador A; Levin D; Azhari R; Swiatlo E; Ling E; Feldman G; Tal M; Dagan R; Mizrachi Nebenzahl Y
    Int J Mol Med; 2016 Apr; 37(4):1127-38. PubMed ID: 26935978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platycodin D2 is a potential less hemolytic saponin adjuvant eliciting Th1 and Th2 immune responses.
    Xie Y; Deng W; Sun H; Li D
    Int Immunopharmacol; 2008 Aug; 8(8):1143-50. PubMed ID: 18550019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel adjuvant G3 induces both Th1 and Th2 related immune responses in mice after immunization with a trivalent inactivated split-virion influenza vaccine.
    Hjertner B; Bengtsson T; Morein B; Paulie S; Fossum C
    Vaccine; 2018 May; 36(23):3340-3344. PubMed ID: 29706292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of Th1/Th2 immune responses to HIV-1 Tat by new pro-GSH molecules.
    Fraternale A; Paoletti MF; Dominici S; Buondelmonte C; Caputo A; Castaldello A; Tripiciano A; Cafaro A; Palamara AT; Sgarbanti R; Garaci E; Ensoli B; Magnani M
    Vaccine; 2011 Sep; 29(40):6823-9. PubMed ID: 21816192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coadministration of the fungal immunomodulatory protein FIP-Fve and a tumour-associated antigen enhanced antitumour immunity.
    Ding Y; Seow SV; Huang CH; Liew LM; Lim YC; Kuo IC; Chua KY
    Immunology; 2009 Sep; 128(1 Suppl):e881-94. PubMed ID: 19740349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Th1/Th2 immune response in diphtheria-tetanus-pertussis vaccine.
    Sugai T; Mori M; Nakazawa M; Ichino M; Naruto T; Kobayashi N; Kobayashi Y; Minami M; Yokota S
    Vaccine; 2005 Nov; 23(46-47):5450-6. PubMed ID: 16006019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to freund's complete adjuvant, but continues to induce T helper 2 cytokine production.
    Brewer JM; Conacher M; Satoskar A; Bluethmann H; Alexander J
    Eur J Immunol; 1996 Sep; 26(9):2062-6. PubMed ID: 8814247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suramin has adjuvant properties and promotes expansion of antigen-specific Th1 and Th2 cells in vivo.
    Denkinger M; Shive CL; Pantenburg B; Forsthuber TG
    Int Immunopharmacol; 2004 Jan; 4(1):15-24. PubMed ID: 14975356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory activity of novel adjuvant formulations based on Montanide ISA oil-based adjuvants and peptidoglycan monomer.
    Habjanec L; Halassy B; Tomasić J
    Int Immunopharmacol; 2008 May; 8(5):717-24. PubMed ID: 18387514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation of TH2 biased immunity with mucosal administration of nanoemulsion adjuvant.
    Bielinska AU; O'Konek JJ; Janczak KW; Baker JR
    Vaccine; 2016 Jul; 34(34):4017-24. PubMed ID: 27317451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary ribonucleotides modulate type 1 and type 2 T-helper cell responses against ovalbumin in young BALB/cJ mice.
    Jyonouchi H; Sun S; Winship T; Kuchan MJ
    J Nutr; 2001 Apr; 131(4):1165-70. PubMed ID: 11285320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.